|
- 2019
Aurone derivatives as Vps34 inhibitors that modulate autophagyDOI: 10.1016/j.apsb.2019.01.016 Keywords: CETSA, cellular thermal shift assay, Co-IP, co-immunoprecipitation, DMEM, Dulbecco?s modified Eagle?s medium, DMSO, dimethyl sulfoxide, EBSS, Earle?s balanced salt solution, ELISA, enzyme-linked immunosorbent assay, FBS, fetal bovine serum, PE, phosphatidylethanolamine, PI, phosphatidylinositol, PI3K, phosphoinositide 3-kinase, PI3P, phosphatidylinositol 3-phosphate, PS, phosphatidylserine Autophagy, Natural products, Vps34, Inhibitor, Structure-based virtual screening, Vesicle trafficking, Heart or liver damage, Aurone derivative Abstract: We report in this study the identification of a natural product-like antagonist (1a) of Vps34 as a potent autophagy modulator via structure-based virtual screening. Aurone derivative 1a strongly inhibited Vps34 activity in cell-free and cell-based assays. Significantly, 1a prevents autophagy in human cells induced either by starvation or by an mTOR inhibitor. In silico modeling and kinetic data revealed that 1a could function as an ATP-competitive inhibitor of Vps34. Moreover, it suppressed autophagy in vivo and without inducing heart or liver damage in mice. 1a could be utilized as a new motif for more selective and efficacious antagonists of Vps34 for the potential treatment of autophagy-related human diseases
|